Stock Ratings / Health Care / AVR / dividends

SMTI (57) ENOV (46) ZJYL (47) CDRE (74) ⌘ Pro Terminal →

Anteris Technologies Global Corp. (AVR) Dividend Safety Gauge & 10-Year DRIP Compounder

$6.42 +5.25% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Anteris Technologies Global Corp. (AVR) carries a Roarable Rating of D- (Sell) with 36/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $625.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-10% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for AVR)Realized 20D OHLCV Swing Band: ±10.6%

CASH DIVIDEND + BUYBACK YIELD

0.6% Total Yield

0% Cash ($0.00/yr) + 0.6% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $17,081

Est. Year-10 Shareholder Yield: $102/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.6K

Yr 1

$11.1K

Yr 2

$11.7K

Yr 3

$12.4K

Yr 4

$13.1K

Yr 5

$13.8K

Yr 6

$14.5K

Yr 7

$15.3K

Yr 8

$16.2K

Yr 9

$17.1K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AVR)

✓Walkthrough of AVR's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

AVR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +4.39%▼ DESCENDING CHANNEL

2026-10-30O $6.33H $6.42L $6.11C $6.42VOL 1.40M

RES: $8.57SUP: $5.61SMA50: $7.56SMA200: $7.39

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AVR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 AVR Butterfly Map → + Track AVR →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -29.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on AVR today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for AVR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for AVR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AVR)

Health Care Rank #778 of 1016 ⚔️ SMTI vs AVR Full Matrix →

1. Head-to-Head Health Care Peer Comparison (AVR vs. SMTI, ENOV, ZJYL, CDRE)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Anteris Technologies Global Corp. (AVR) ranks #778 by composite RQD confidence (36/100, grade D-) and #416 by equity capitalization ($625.9M). Within this direct 5-issuer industry benchmark cohort, SMTI leads on earnings valuation at 8.1x trailing P/E, while SMTI leads on capital efficiency and profitability with 16.3% ROIC and 92.7% gross margin. CDRE currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with AVR at 36/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
AVR ACTIVE Anteris Technologies Global Corp.	D-	36/100	—	70.3%	-35.0%	+5.25%	$625.9M	Benchmark Subject
SMTI Sanara MedTech Inc.	D+	57/100	8.1x	92.7%	16.3%	+0.11%	$302.4M	/smti-vs-avr →
ENOV Enovis Corporation	D	46/100	—	59.8%	-32.7%	+4.11%	$1.32B	/enov-vs-avr →
ZJYL JIN MEDICAL INTERNATIONAL LTD. (Class A)	D	47/100	—	29.2%	—	-2.10%	$294.2M	/zjyl-vs-avr →
CDRE Cadre Holdings Inc.	B	74/100	30.2x	42.5%	11.0%	+3.81%	$1.33B	/cdre-vs-avr →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2024–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0002011514

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Anteris Technologies Global Corp. (AVR) reported GAAP revenue of $1.9M (-29.2% vs. FY2024 revenue of $2.7M ) , GAAP net income of -$94.1M, operating cash flow of -$77.8M, and free cash flow of -$79.8M (-25.6% YoY). On the balance sheet, AVR closed FY2025 with $23.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.9M	-$94.1M	-$77.8M	-$79.8M	$23.0M	—
FY2024 (FY)	2024-12-31	$2.7M	-$76.3M	-$61.2M	-$63.5M	$80.7M	—

3. AVR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is AVR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Anteris Technologies Global Corp. (NASDAQ: AVR) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 36/100 at a spot price of $6.42 (+5.25% 1D, market cap $625.9M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, AVR ranks #778 in composite RQD confidence.

How does AVR compare to SMTI and ENOV in the Health Care sector?

Within the Health Care sector (Industrial Specialties), AVR carries a Roarable D- (36/100 RQD), trailing P/E of N/A, gross margin of 70.3%, and ROIC of -35.0%. By comparison, SMTI (Sanara MedTech Inc.) holds a D+ grade (57/100 RQD, P/E 8.1x, ROIC 16.3%, cap $302.4M) and ENOV (Enovis Corporation) posts a D grade (46/100 RQD, P/E N/A, ROIC -32.7%, cap $1.32B). Among the 5-stock peer group, SMTI leads on earnings multiple (8.1x) while SMTI leads on capital efficiency (16.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for AVR?

Per AVR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0002011514), Anteris Technologies Global Corp. generated $1.9M in revenue (-29.2% YoY), -$94.1M in net income, and -$79.8M in free cash flow against $23.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is AVR trading relative to its 50-day, 200-day, and 52-week technical levels?

AVR last traded at $6.42 (+5.25% on volume of 2,822,317 shares), positioning the stock -15.08% below its 50-day simple moving average ($7.56) and -13.13% below its 200-day simple moving average ($7.39). Across its 52-week range of $3.30 to $11.06, AVR sits at the 40.2% percentile with a 14-day RSI of 41.3 (NEUTRAL RANGE) and an implied next-earnings move of ±10.6% ($5.74 to $7.10).

AVR Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does AVR pay a dividend and is it safe?

Anteris Technologies Global Corp. (AVR) offers a 0% cash dividend yield ($0.00 annualized) and 0.6% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: AVR RQD Cockpit AVR 12M Forecast AVR Earnings & Move AVR Dividends & DRIP AVR Insiders & 13F AVR Whale Options AVR Profit Sankey AVR News & Why